GILDGilead Sciences, Inc.
GILD
Gilead Sciences, Inc.77,721
Mkt Cap
$170.34BVolume
7.36M52W High
$157.2952W Low
$93.37PE Ratio
20.25GILD Fundamentals
Price
$137.34Prev Close
$137.21Open
$139.6850D MA
$142.25Beta
0.37Avg. Volume
7.91MEPS (Annual)
$6.78P/B
7.51Rev/Employee
$1.73M$169,882.70
Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases
Gilead Sciences, Inc. (Nasdaq: GILD) announced today it has entered into a definitive agreement to acquire Ouro Medicines, a privately held biotechnology company focused on developing T cell engager...
Business Wire·3h ago
Top Pharmaceutical Stocks Worth Watching - March 23rd
Eli Lilly and Company, AbbVie, Pfizer, Novo Nordisk A/S, Gilead Sciences, Abbott Laboratories, and Insmed are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufact...
MarketBeat·8h ago
Wealth Enhancement Advisory Services LLC Has $77.22 Million Stock Holdings in Gilead Sciences, Inc. $GILD
Wealth Enhancement Advisory Services LLC increased its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 6.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 633,185 share...
MarketBeat·14h ago
Nordea Investment Management AB Increases Position in Gilead Sciences, Inc. $GILD
Nordea Investment Management AB boosted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 16.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC...
MarketBeat·2d ago
New England Research & Management Inc. Buys New Stake in Gilead Sciences, Inc. $GILD
New England Research & Management Inc. bought a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 11,700 shares of the biopharmaceutical company's stock, v...
MarketBeat·2d ago
Top Pharmaceutical Stocks To Research - March 21st
Abbott Laboratories, AbbVie, Eli Lilly and Company, Bristol Myers Squibb, and Gilead Sciences are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool...
MarketBeat·2d ago
IAM Advisory LLC Takes $1.27 Million Position in Gilead Sciences, Inc. $GILD
IAM Advisory LLC acquired a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund...
MarketBeat·3d ago
BCGM Wealth Management LLC Makes New Investment in Gilead Sciences, Inc. $GILD
BCGM Wealth Management LLC acquired a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 11,746 shares of the biopharmaceutical company's stock, valued at appr...
MarketBeat·3d ago
Confluence Investment Management LLC Trims Stock Position in Gilead Sciences, Inc. $GILD
Confluence Investment Management LLC trimmed its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 4.5% in the 4th quarter, according to its most recent disclosure with the SEC. The...
MarketBeat·4d ago
<
1
2
...
>